|   | |
| Names | |
|---|---|
| Preferred IUPAC name N,N,N-Trimethyl-2-[(methylphosphonofluoridoyl)oxy]ethan-1-aminium | |
| Other names Methylfluorophosphorylcholine, MFPCh | |
| Identifiers | |
| 3D model (JSmol) | |
| ChemSpider | |
|  PubChem CID | |
|  CompTox Dashboard (EPA) | |
| 
 | |
| 
 | |
| Properties | |
| C6H16FNO2P | |
| Molar mass | 184.171 g·mol−1 | 
| Hazards | |
| Occupational safety and health (OHS/OSH): | |
| Main hazards | Extremely toxic | 
| Lethal dose or concentration (LD, LC): | |
| LD50 (median dose) | 100 μg/kg (mice, intraperitoneal) [1] | 
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Methylfluorophosphonylcholine (MFPCh) is an extremely toxic chemical compound related to the G-series nerve agents. It is an extremely potent acetylcholinesterase inhibitor which is around 100 times more potent than sarin at inhibiting acetylcholinesterase in vitro, [2] and around 10 times more potent in vivo, depending on route of administration and animal species tested. [3] MFPCh is resistant to oxime reactivators, meaning the acetylcholinesterase inhibited by MFPCh can't be reactivated by cholinesterase reactivators. [2] [4] [5] MFPCh also acts directly on the acetylcholine receptors. [6] MFPCh is a relatively unstable compound and degrades rapidly in storage, so despite its enhanced toxicity it was not deemed suitable to be weaponised for military use. [7]